Posted by Michael Wonder on 28 Jul 2016
TGA approves Belkyra (deoxycholic acid)
28 July 2016 - The TGA has approved Allergan's Belkyra (deoxycholic acid).
The TGA approved Belkyra on 21 July 2016 for the improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults.
